Matches in SemOpenAlex for { <https://semopenalex.org/work/W2071330352> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W2071330352 endingPage "2878" @default.
- W2071330352 startingPage "2873" @default.
- W2071330352 abstract "Background. This Phase III trial was performed to compare the roles of oral etoposide and intravenous (i. v.) vinblastine in the treatment of Mediterranean Kaposi's Sarcoma (MEKS) in elderly patients with severe disease (Stages II, Ac/B, III, and IV). Patients and Methods. Sixty-five patients were randomized to receive either oral etoposide (60 mg/m2 on Days 1–3 during the first course; 60 mg/m2 on Days 1–4 during the second course, and 60 mg/m2 on Days 1–5 during the third course; the courses were recycled every 3 weeks) or an i. v. bolus of vinblastine (3 mg/m2 weekly for 3 weeks, and then 6 mg/m2 every 3 weeks). Results. No significant difference between the two drugs was observed in terms of response rates (etoposide, 73.5% vs. vinblastine, 58%; P = 0.3), duration of response, or survival (median not yet reached at a median followup of 38 months). Side effects of both treatments were limited, although myelotoxicity was more evident in the vinblastine arm. Conclusions. Although it is feasible and well tolerated, the oral administration of etoposide at these doses and in this regimen does not appear superior to vinblastine in the treatment of MEKS. Further evaluation of a more intensive schedule in large cooperative clinical trials is needed to establish the role of this drug in comparison with reference treatments." @default.
- W2071330352 created "2016-06-24" @default.
- W2071330352 creator A5000453166 @default.
- W2071330352 creator A5008585325 @default.
- W2071330352 creator A5018055551 @default.
- W2071330352 creator A5022430309 @default.
- W2071330352 creator A5067827948 @default.
- W2071330352 creator A5084773667 @default.
- W2071330352 creator A5090122955 @default.
- W2071330352 date "1994-11-15" @default.
- W2071330352 modified "2023-09-27" @default.
- W2071330352 title "Mediterranean Kaposi's sarcoma in the elderly. A randomized study of oral etoposide versus vinblastine" @default.
- W2071330352 cites W1962493215 @default.
- W2071330352 cites W1971653559 @default.
- W2071330352 cites W1982888014 @default.
- W2071330352 cites W2002795047 @default.
- W2071330352 cites W2032569681 @default.
- W2071330352 cites W2047411131 @default.
- W2071330352 cites W2059273049 @default.
- W2071330352 cites W208570163 @default.
- W2071330352 cites W2088281273 @default.
- W2071330352 cites W2167805334 @default.
- W2071330352 cites W2338588495 @default.
- W2071330352 cites W4293241248 @default.
- W2071330352 cites W2216763478 @default.
- W2071330352 doi "https://doi.org/10.1002/1097-0142(19941115)74:10<2873::aid-cncr2820741021>3.0.co;2-1" @default.
- W2071330352 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7954250" @default.
- W2071330352 hasPublicationYear "1994" @default.
- W2071330352 type Work @default.
- W2071330352 sameAs 2071330352 @default.
- W2071330352 citedByCount "49" @default.
- W2071330352 countsByYear W20713303522012 @default.
- W2071330352 countsByYear W20713303522013 @default.
- W2071330352 countsByYear W20713303522014 @default.
- W2071330352 countsByYear W20713303522015 @default.
- W2071330352 countsByYear W20713303522016 @default.
- W2071330352 countsByYear W20713303522018 @default.
- W2071330352 countsByYear W20713303522019 @default.
- W2071330352 countsByYear W20713303522021 @default.
- W2071330352 countsByYear W20713303522022 @default.
- W2071330352 crossrefType "journal-article" @default.
- W2071330352 hasAuthorship W2071330352A5000453166 @default.
- W2071330352 hasAuthorship W2071330352A5008585325 @default.
- W2071330352 hasAuthorship W2071330352A5018055551 @default.
- W2071330352 hasAuthorship W2071330352A5022430309 @default.
- W2071330352 hasAuthorship W2071330352A5067827948 @default.
- W2071330352 hasAuthorship W2071330352A5084773667 @default.
- W2071330352 hasAuthorship W2071330352A5090122955 @default.
- W2071330352 hasBestOaLocation W20713303521 @default.
- W2071330352 hasConcept C126322002 @default.
- W2071330352 hasConcept C141071460 @default.
- W2071330352 hasConcept C168563851 @default.
- W2071330352 hasConcept C2776694085 @default.
- W2071330352 hasConcept C2777132456 @default.
- W2071330352 hasConcept C2778119113 @default.
- W2071330352 hasConcept C2781413609 @default.
- W2071330352 hasConcept C43376680 @default.
- W2071330352 hasConcept C71924100 @default.
- W2071330352 hasConcept C90924648 @default.
- W2071330352 hasConceptScore W2071330352C126322002 @default.
- W2071330352 hasConceptScore W2071330352C141071460 @default.
- W2071330352 hasConceptScore W2071330352C168563851 @default.
- W2071330352 hasConceptScore W2071330352C2776694085 @default.
- W2071330352 hasConceptScore W2071330352C2777132456 @default.
- W2071330352 hasConceptScore W2071330352C2778119113 @default.
- W2071330352 hasConceptScore W2071330352C2781413609 @default.
- W2071330352 hasConceptScore W2071330352C43376680 @default.
- W2071330352 hasConceptScore W2071330352C71924100 @default.
- W2071330352 hasConceptScore W2071330352C90924648 @default.
- W2071330352 hasIssue "10" @default.
- W2071330352 hasLocation W20713303521 @default.
- W2071330352 hasLocation W20713303522 @default.
- W2071330352 hasOpenAccess W2071330352 @default.
- W2071330352 hasPrimaryLocation W20713303521 @default.
- W2071330352 hasRelatedWork W180096063 @default.
- W2071330352 hasRelatedWork W1970012110 @default.
- W2071330352 hasRelatedWork W2080363984 @default.
- W2071330352 hasRelatedWork W2086955530 @default.
- W2071330352 hasRelatedWork W2323139555 @default.
- W2071330352 hasRelatedWork W2387113950 @default.
- W2071330352 hasRelatedWork W2406992502 @default.
- W2071330352 hasRelatedWork W2410852431 @default.
- W2071330352 hasRelatedWork W2417697013 @default.
- W2071330352 hasRelatedWork W2418486715 @default.
- W2071330352 hasVolume "74" @default.
- W2071330352 isParatext "false" @default.
- W2071330352 isRetracted "false" @default.
- W2071330352 magId "2071330352" @default.
- W2071330352 workType "article" @default.